OpenURL Connection Search

Select item for more details and to access through your institution.

Williamsburg Conference on Biological and Immunological Treatments for Cancer, 1992.
Published in:
1993
By:
- Borden, Ernest C.;
- Schlom, Jeffrey;
- Borden, E C;
- Schlom, J
Publication type:
journal article
Human Biologic Response Modification by Interferon in the Absence of Measurable Serum Concentrations: A Comparative Trial of Subcutaneous and Intravenous Interferon-β serine.
Published in:
JNCI: Journal of the National Cancer Institute, 1989, v. 81, n. 14, p. 1061
By:
- Goldstein, D.;
- Sielaff, K. M.;
- Stores, B. E.;
- Brown, R. R.;
- Datta, S. P.;
- Witt, P. L.;
- Teitelbaum, A. P.;
- Smalley, R. V.;
- Borden, E. C.
Publication type:
Article
Reversal of methylation silencing of Apo2L/TRAIL receptor 1 (DR4) expression overcomes resistance of SK-MEL-3 and SK-MEL-28 melanoma cells to interferons (IFNs) or Apo2L/TRAIL.
Published in:
Oncogene, 2008, v. 27, n. 4, p. 490, doi. 10.1038/sj.onc.1210655
By:
- Bae, S. I.;
- Cheriyath, V.;
- Jacobs, B. S.;
- Reu, F. J.;
- Borden, E. C.
Publication type:
Article
Phase IA/IB Evaluation of Mammalian Cell-derived Glycosylated Recombinant Human Interleukin (SIGOSIX) before and after Cytotoxic Chemotherapy.
Published in:
Annals of the New York Academy of Sciences, 1995, v. 762, n. 1, p. 359, doi. 10.1111/j.1749-6632.1995.tb32340.x
By:
- RITCH, P. S.;
- KEEVER, C.;
- SCHILLER, J.;
- RIVKIN, S.;
- WITT, P. L.;
- GROSSBERG, S. E.;
- TRUITT, R. L.;
- BURRIS, H.;
- HOFF, D. D.;
- VAICKUS, L.;
- DRECHSLER, D.;
- BORDEN, E. C.;
- GALAZKA, A.;
- BREITMEYER, J. B.;
- ABDUL-AHAD, A.
Publication type:
Article
Leukocyte-derived interferon (alpha) in human breast carcinoma. The American Cancer Society phase II trial.
Published in:
1982
By:
- Borden, Ernest C.;
- Holland, James F.;
- Dao, Thomas L.;
- Gutterman, Jordan U.;
- Wiener, Leo;
- Chang, Yuang-Chi;
- Patel, Jashbhaik;
- Borden, E C;
- Holland, J F;
- Dao, T L;
- Gutterman, J U;
- Wiener, L;
- Chang, Y C;
- Patel, J
Publication type:
journal article
Human polyomavirus infections with JC virus and BK virus in renal transplant patients.
Published in:
1980
By:
- Hogan, Thomas F.;
- Borden, Ernest C.;
- McBain, J.A.;
- Padgett, B.L.;
- Walker, D.L.;
- Hogan, T F;
- Borden, E C
Publication type:
journal article
Pathologic analysis of advanced adult soft tissue sarcomas, bone sarcomas, and mesotheliomas. The Eastern Cooperative Oncology Group (ECOG) experience.
Published in:
1989
By:
- Shiraki, Masanori;
- Enterline, Horatio T.;
- Brooks, John J.;
- Cooper, Norman S.;
- Hirschl, Simon;
- Roth, Joel A.;
- Rao, Uma N.;
- Enzinger, Franz M.;
- Amato, David A.;
- Borden, Ernest C.;
- Shiraki, M;
- Enterline, H T;
- Brooks, J J;
- Cooper, N S;
- Hirschl, S;
- Roth, J A;
- Rao, U N;
- Enzinger, F M;
- Amato, D A;
- Borden, E C
Publication type:
journal article
Phase II evaluation of a combination of mitomycin C, vincristine, and cisplatin in advanced non-small cell lung cancer.
Published in:
1986
By:
- Chang, Alex Yuang-Chi;
- Philip Kuebler, J.;
- Tormey, Douglass C.;
- Anderson, Susan;
- Pandya, Kishan J.;
- Borden, Ernest C.;
- Davis, Thomas E.;
- Trump, Donald L.;
- Chang, A Y;
- Kuebler, J P;
- Tormey, D C;
- Anderson, S;
- Pandya, K J;
- Borden, E C;
- Davis, T E;
- Trump, D L
Publication type:
journal article
o,p'-DDD (mitotane) therapy of adrenal cortical carcinoma: observations on drug dosage, toxicity, and steroid replacement.
Published in:
1978
By:
- Hogan, T. F.;
- Citrin, D. L.;
- Johnson, B. M.;
- Nakamura, S.;
- Davis, T. E.;
- Borden, E. C.
Publication type:
journal article
Recombinant interferon-gamma preserves human granulocyte bactericidal and chemoluminescence activities.
Published in:
1993
By:
- Brar, D W;
- Borden, E C;
- Proctor, R A
Publication type:
journal article
A Notch1-neuregulin1 autocrine signaling loop contributes to melanoma growth.
Published in:
Oncogene, 2012, v. 31, n. 43, p. 4609, doi. 10.1038/onc.2011.606
By:
- Zhang, K;
- Wong, P;
- Zhang, L;
- Jacobs, B;
- Borden, E C;
- Aster, J C;
- Bedogni, B
Publication type:
Article
G1P3, an interferon- and estrogen-induced survival protein contributes to hyperplasia, tamoxifen resistance and poor outcomes in breast cancer.
Published in:
Oncogene, 2012, v. 31, n. 17, p. 2222, doi. 10.1038/onc.2011.393
By:
- Cheriyath, V;
- Kuhns, M A;
- Jacobs, B S;
- Evangelista, P;
- Elson, P;
- Downs-Kelly, E;
- Tubbs, R;
- Borden, E C
Publication type:
Article
Final analysis of the ECOG I-COPA trial (E6484) in patients with non-Hodgkin's lymphoma treated with interferon alfa (IFN-alpha2a) plus an anthracycline-based induction regimen.
Published in:
2001
By:
- Smalley, R V;
- Weller, E;
- Hawkins, M J;
- Oken, M M;
- O’Connell, M J;
- Haase-Statz, S;
- Borden, E C;
- O'Connell, M J
Publication type:
journal article
Hypertrophic osteoarthropathy and pregnancy.
Published in:
1969
By:
- Borden, Ernest C.;
- Holling, H. Edward;
- Borden, E C;
- Holling, H E
Publication type:
journal article
Further clinical studies with megestrol acetate in advanced breast cancer.
Published in:
1976
By:
- Ansfield, Fred J.;
- Davis, Hugh L.;
- Ramirez, Guillermo;
- Davis, Thomas E.;
- Borden, Ernest C.;
- Johnson, Robert O.;
- Bryan, George T.;
- Ansfield, F J;
- Davis, H L Jr;
- Ramirez, G;
- Davis, T E;
- Borden, E C;
- Johnson, R O;
- Bryan, G T
Publication type:
journal article
Gene Modulatory Effects, Pharmacokinetics, and Clinical Tolerance of Interferon-α1b: A Second Member of the Interferon-α Family.
Published in:
Clinical Pharmacology & Therapeutics, 2007, v. 81, n. 3, p. 354, doi. 10.1038/sj.clpt.6100081
By:
- Masci, P.;
- Olencki, T.;
- Wood, L.;
- Rybicki, L.;
- Jacobs, B.;
- Williams, B.;
- Faber, P.;
- Bukowski, R.;
- Tong, K.;
- Borden, E. C.
Publication type:
Article
Randomized comparison of doxorubicin and vindesine to doxorubicin for patients with metastatic soft-tissue sarcomas.
Published in:
1990
By:
- Borden, Ernest C.;
- Amato, David A.;
- Edmonson, John H.;
- Ritch, Paul S.;
- Shiraki, Masanori;
- Borden, E C;
- Amato, D A;
- Edmonson, J H;
- Ritch, P S;
- Shiraki, M
Publication type:
journal article
Enhancement of monocyte class I and II histocompatibility antigen expression in man by in vivo β-interferon.
Published in:
Clinical & Experimental Immunology, 1987, v. 69, n. 1, p. 107
By:
- Spear, G. T.;
- Paulnock, D. M.;
- Jordan, R. L.;
- Meltzer, D. M.;
- Merritt, J. A.;
- Borden, E. C.
Publication type:
Article
Potentiation of apoptosis by histone deacetylase inhibitors and doxorubicin combination: cytoplasmic cathepsin B as a mediator of apoptosis in multiple myeloma.
Published in:
2011
By:
- Cheriyath, V.;
- Kuhns, M. A.;
- Kalaycio, M. E.;
- Borden, E. C.
Publication type:
journal article
Downregulation of Bcl-2, FLIP or IAPs (XIAP and survivin) by siRNAs sensitizes resistant melanoma cells to Apo2L/TRAIL-induced apoptosis.
Published in:
Cell Death & Differentiation, 2004, v. 11, n. 8, p. 915, doi. 10.1038/sj.cdd.4401416
By:
- Chawla-Sarkar, M.;
- Bae, S. I.;
- Reu, F. J.;
- Jacobs, B. S.;
- Lindner, D. J.;
- Borden, E. C.
Publication type:
Article
Stage-associated overexpression of the ubiquitin-like protein, ISG15, in bladder cancer.
Published in:
2006
By:
- Andersen, J. B.;
- Aaboe, M.;
- Borden, E. C.;
- Goloubeva, O. G.;
- Hassel, B. A.;
- Ørntoft, T. F.;
- Orntoft, T F
Publication type:
journal article

Found: 21